CoChat

Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism

Open access

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

The insulin/insulin-like growth factor-1 signalling (IIS) pathway regulates cellular and organismal metabolism and controls the rate of aging. Gain-of-function mutations in p110α, the principal mammalian IIS-responsive isoform of PI 3-kinase (PI3K), promote cancer. In contrast, loss-of-function mutations in p110α impair insulin signalling and cause insulin resistance, inducing a pre-diabetic state. It remains unknown if long-term p110α inactivation induces further metabolic deterioration over time, leading to overt unsustainable pathology. Surprisingly, we find that chronic p110α partial inactivation in mice protects from age-related reduction in insulin sensitivity, glucose tolerance and fat accumulation, and extends the lifespan of male mice. This beneficial effect of p110α inactivation derives in part from a suppressed down-regulation of insulin receptor substrate (IRS) protein levels induced by age-related hyperinsulinemia, and correlates with enhanced insulin-induced Akt signalling in aged p110α-deficient mice. This temporal metabolic plasticity upon p110α inactivation indicates that prolonged PI3K inhibition, as intended in human cancer treatment, might not negatively impact on organismal metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201201953

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Middle-aged p110αD933A/WT male mice are resistant to age-related fat accumulation and display better glucose homeostasis than WT littermates. Parameters were assessed in approximately 500-day-old male mice. Bars represent mean ± standard error. Statistical comparisons were performed with Student's t-test. A. Body weight (n = 17 per genotype). B. Epididymal fat pad weight (n = 3 per genotype). C. Cumulative food intake over 10 days (left panel), expressed per kg of body weight (right panel; n = 9 p110αD933A/WT–7 WT). D. Fasting plasma insulin (n = 5 per genotype). E. Fasting plasma glucose (n = 11 p110αD933A/WT–12 WT). F. Glucose tolerance injected intraperitoneally with 2 g glucose/kg body weight (n = 11 p110αWT/D933A–12 WT).
Figure 1 Middle-aged p110αD933A/WT male mice are resistant to age-related fat accumulation and display better glucose homeostasis than WT littermates. Parameters were assessed in approximately 500-day-old male mice. Bars represent mean ± standard error. Statistical comparisons were performed with Student's t-test. A. Body weight (n = 17 per genotype). B. Epididymal fat pad weight (n = 3 per genotype). C. Cumulative food intake over 10 days (left panel), expressed per kg of body weight (right panel; n = 9 p110αD933A/WT–7 WT). D. Fasting plasma insulin (n = 5 per genotype). E. Fasting plasma glucose (n = 11 p110αD933A/WT–12 WT). F. Glucose tolerance injected intraperitoneally with 2 g glucose/kg body weight (n = 11 p110αWT/D933A–12 WT).CC BY · PubMed Central
Figure 2 Middle-aged p110αD933/WT mice fed a high fat diet maintain better metabolic profiles than WT littermates. Male mice were fed a high fat diet (45% calories derived from fat) at 66 weeks of age and for 14 weeks and were subsequently metabolically phenotyped as follows: A. Intraperitoneal insulin (2 U/kg) tolerance test (n = 6 per genotype). B. Intraperitoneal glucose (1 g/kg) tolerance tests (n = 6 per genotype). C. Insulin-stimulated Akt phosphorylation. Mice were injected with insulin (0.25 mU/g) via the inferior vena cava and Akt phosphorylation was assessed by quantitative immunoblot analysis in tissue homogenates [liver, gastrocnemius muscle, and white adipose tissue (WAT)]. Each lane represents an individual mouse (n = 4 per genotype). Signal intensity was quantified and data (mean ± standard deviation) are shown in the graphs below the respective blots.
Figure 2 Middle-aged p110αD933/WT mice fed a high fat diet maintain better metabolic profiles than WT littermates. Male mice were fed a high fat diet (45% calories derived from fat) at 66 weeks of age and for 14 weeks and were subsequently metabolically phenotyped as follows: A. Intraperitoneal insulin (2 U/kg) tolerance test (n = 6 per genotype). B. Intraperitoneal glucose (1 g/kg) tolerance tests (n = 6 per genotype). C. Insulin-stimulated Akt phosphorylation. Mice were injected with insulin (0.25 mU/g) via the inferior vena cava and Akt phosphorylation was assessed by quantitative immunoblot analysis in tissue homogenates [liver, gastrocnemius muscle, and white adipose tissue (WAT)]. Each lane represents an individual mouse (n = 4 per genotype). Signal intensity was quantified and data (mean ± standard deviation) are shown in the graphs below the respective blots.CC BY · PubMed Central
Figure 3 Chronic p110α inhibition promotes IRS-dependent signalling. A. p110α inhibition prevents IRS downregulation induced by chronic insulin treatment in C2C12 myotubes. C2C12 myotubes (cultured in medium with 5.5 mM glucose) were pre-treated for 16 h with insulin (10 nM) in the presence or absence of A66 (2 µM) or TGX-221 (1 µM). Monolayers were then rinsed with phosphate-buffered saline and lysed either directly for detection of IRS and S6K T389 phosphorylation or after 1 h culture in serum-free medium and re-stimulation with insulin (10 nM for 10 min; referred to in the figure as ‘acute insulin’) for detection of Akt T308 phosphorylation. Lysates were processed for immunoblot analysis with the indicated antibodies. Panels have been rearranged for clarity, but they are from the same immunoblots. Signal intensity was quantified and normalized to that of vinculin, used as a loading control in all immunoblots. B. Quantitative data (mean ± standard deviation) from three independent experiments performed as in A. Statistical comparisons were performed with Student's t-test. C. IRS protein levels (mean ± standard deviation) as determined by immunoblot analysis in epididymal fat pads [white adipose tissue (WAT)] and gastrocnemius muscle homogenates of 80 week old male p110αD933A/WT mice and WT littermates (n = 4 per genotype).
Figure 3 Chronic p110α inhibition promotes IRS-dependent signalling. A. p110α inhibition prevents IRS downregulation induced by chronic insulin treatment in C2C12 myotubes. C2C12 myotubes (cultured in medium with 5.5 mM glucose) were pre-treated for 16 h with insulin (10 nM) in the presence or absence of A66 (2 µM) or TGX-221 (1 µM). Monolayers were then rinsed with phosphate-buffered saline and lysed either directly for detection of IRS and S6K T389 phosphorylation or after 1 h culture in serum-free medium and re-stimulation with insulin (10 nM for 10 min; referred to in the figure as ‘acute insulin’) for detection of Akt T308 phosphorylation. Lysates were processed for immunoblot analysis with the indicated antibodies. Panels have been rearranged for clarity, but they are from the same immunoblots. Signal intensity was quantified and normalized to that of vinculin, used as a loading control in all immunoblots. B. Quantitative data (mean ± standard deviation) from three independent experiments performed as in A. Statistical comparisons were performed with Student's t-test. C. IRS protein levels (mean ± standard deviation) as determined by immunoblot analysis in epididymal fat pads [white adipose tissue (WAT)] and gastrocnemius muscle homogenates of 80 week old male p110αD933A/WT mice and WT littermates (n = 4 per genotype).CC BY · PubMed Central
Figure 4 Extension of lifespan of male p110αD933A/WT mice. A. Survival curves of p110αD933A/WT mice. Cohorts of p110αD933A/WT (n = 26) and WT (n = 42) male mice were monitored from birth to death as described in Materials and Methods. Median lifespan was 818 days (p110αWT/D933A) versus 799 days (WT). The difference between the curves is marginally statistically significant (log-rank test, p = 0.0545, x2 = 3.697). B. Survival analysis limited to mice surviving to 500 days of age (n = 21 for p110αWT/D933A and n = 40 for WT). Median life span was 852 days (p110αWT/D933A) versus 805 days (WT). The difference between the curves is statistically significant (log-rank test, p = 0.0094, x2 = 6.739).
Figure 4 Extension of lifespan of male p110αD933A/WT mice. A. Survival curves of p110αD933A/WT mice. Cohorts of p110αD933A/WT (n = 26) and WT (n = 42) male mice were monitored from birth to death as described in Materials and Methods. Median lifespan was 818 days (p110αWT/D933A) versus 799 days (WT). The difference between the curves is marginally statistically significant (log-rank test, p = 0.0545, x2 = 3.697). B. Survival analysis limited to mice surviving to 500 days of age (n = 21 for p110αWT/D933A and n = 40 for WT). Median life span was 852 days (p110αWT/D933A) versus 805 days (WT). The difference between the curves is statistically significant (log-rank test, p = 0.0094, x2 = 6.739).CC BY · PubMed Central
Figure 5 Schematic overview of the beneficial impact of chronic p110α inactivation on age-related deterioration of insulin sensitivity. The levels of IRS are key to insulin signalling. Chronic stimulation with insulin, as occurs in hyperinsulinemia, downregulates IRS via a negative feedback loop that involves IRS phosphorylation by S6K, exacerbating age-related insulin resistance. Reduced p110α activity as a consequence of loss-of-function mutation (D933A) or pharmacologic inhibition (e.g. A66) attenuates S6K activity, protecting against chronic insulin-induced IRS depletion, thus promoting insulin sensitivity.
Figure 5 Schematic overview of the beneficial impact of chronic p110α inactivation on age-related deterioration of insulin sensitivity. The levels of IRS are key to insulin signalling. Chronic stimulation with insulin, as occurs in hyperinsulinemia, downregulates IRS via a negative feedback loop that involves IRS phosphorylation by S6K, exacerbating age-related insulin resistance. Reduced p110α activity as a consequence of loss-of-function mutation (D933A) or pharmacologic inhibition (e.g. A66) attenuates S6K activity, protecting against chronic insulin-induced IRS depletion, thus promoting insulin sensitivity.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 102

Metadata

Authors
Foukas, L. C., Bilanges, B., Bettedi, L., Pearce, W., Ali, K., Sancho, S., Withers, D. J., & Vanhaesebroeck, B.
Affiliations
  • University College London (GB)
  • Queen Mary University of London (GB)
  • Laboratoire Mouvement Sport Santé (FR)
  • Imperial College London (GB)
Corresponding author
  • Foukas, Lazaros C.
  • Vanhaesebroeck, Bart
Venue
EMBO Molecular Medicine
Published
2013-03-11
Volume
5
Issue
4
Pages
563-571
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2121232254
Cited by
91
References
41
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 6 · 2022: 9 · 2021: 16 · 2020: 10 · 2019: 3 · 2018: 4 · 2017: 10 · 2016: 4 · 2015: 16 · 2014: 4 · 2013: 3
FWCI
4.01
Type
journal article
Language
en
Open access
Licence
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Queen Mary University of London
  • Wellcome Trust (098565, 093115/Z/10/Z)
  • Cancer Research UK (C23338, C23338/A10200, 15965)
  • Diabetes Research and Wellness Foundation
  • Royal Society
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council (BB/I007806/1, BB/H020527/2)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
PI3K inhibition, aging, lifespan extension, insulin resistance, glucose tolerance, fat deposition, insulin receptor substrate, Akt signaling, hyperinsulinemia, metabolic plasticity, cancer treatment side effects
MeSH terms
Animals, Fats, Female, Glucose, Humans, Insulin, Male, Metabolic Diseases, Mice, Inbred C57BL, Time Factors, Mice, Knockout, Gene Silencing, Mice, Insulin Receptor Substrate Proteins, Class I Phosphatidylinositol 3-Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism. https://app.cochat.ai/papers/10.1002/emmm.201201953
The paper
Foukas, L. C., Bilanges, B., Bettedi, L., Pearce, W., Ali, K., Sancho, S., Withers, D. J., & Vanhaesebroeck, B. (2013). Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201201953

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.